EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Genomics to AI: Revolutionizing Precision Medicine in Oncology

Giulia Calvino, Juliette Farro, Stefania Zampatti, Cristina Peconi, Domenica Megalizzi, Giulia Trastulli, Sarah Andreucci, Raffaella Cascella, Claudia Strafella, Carlo Caltagirone, Federico Grifalchi, Emiliano Giardina

Applied Sciences · 11.06.2025 · 15 (12) · 6578

DOI: 10.3390/app15126578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 11.06.2025. Verfasst von Giulia Calvino und 11 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing burden of cancer globally necessitates innovative approaches for diagnosis, prognosis, and treatment. This article explores the transformative impact of genomics and artificial intelligence (AI) in precision oncology, addressing how their convergence is reshaping cancer care and its challenges.

Methods

This review synthesizes current research on the applications of genomics, including next-generation sequencing, and AI, such as machine learning and deep learning, across the cancer care continuum. It examines their roles in identifying genetic variants, assessing cancer risk, guiding targeted therapies and immunotherapy, predicting treatment response, and enabling early detection through liquid biopsies.

Results

Genomics and AI are revolutionizing oncology by enabling personalized treatment strategies, improving early detection, and overcoming drug resistance. AI enhances the interpretation of complex genomic data, facilitates drug repurposing, and accelerates the development of novel therapeutics. However, challenges remain regarding data standardization, interpretability, bias in AI algorithms, and ethical considerations.

Conclusions

The integration of genomics and AI holds immense potential to advance precision oncology, offering more effective, equitable, and sustainable cancer care. Addressing current challenges and fostering interdisciplinary training will be crucial to fully harness these technologies and redefine oncology practice.

Zitieren

APA

Calvino, G., Farro, J., Zampatti, S., Peconi, C., Megalizzi, D., Trastulli, G., Andreucci, S., Cascella, R., Strafella, C., Caltagirone, C., Grifalchi, F., & Giardina, E. (2025). From Genomics to AI: Revolutionizing Precision Medicine in Oncology. Applied Sciences, 15(12), 6578. https://doi.org/10.3390/app15126578

Vancouver

Calvino G, Farro J, Zampatti S, Peconi C, Megalizzi D, Trastulli G, et al. From Genomics to AI: Revolutionizing Precision Medicine in Oncology. Applied Sciences. 2025;15(12):6578. doi:10.3390/app15126578

BibTeX
@article{Calvino2025,
  author = {Calvino, Giulia and Farro, Juliette and Zampatti, Stefania and Peconi, Cristina and Megalizzi, Domenica and Trastulli, Giulia and Andreucci, Sarah and Cascella, Raffaella and Strafella, Claudia and Caltagirone, Carlo and Grifalchi, Federico and Giardina, Emiliano},
  title = {From Genomics to AI: Revolutionizing Precision Medicine in Oncology},
  journal = {Applied Sciences},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {6578},
  doi = {10.3390/app15126578}
}
Kostenlos starten →